Long‐term efficacy of telemedicine for patients with locally advanced basal cell carcinoma during COVID‐19 pandemic

Detalles Bibliográficos
Autores principales: Villani, Alessia, Potestio, Luca, Fabbrocini, Gabriella, di Vico, Francesca, Costa, Claudia, Scalvenzi, Massimiliano
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley & Sons, Inc. 2022
Materias:
Letters
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9787710/
https://www.ncbi.nlm.nih.gov/pubmed/36018282
http://dx.doi.org/10.1111/dth.15786
_version_ 1784858577385553920
author Villani, Alessia
Potestio, Luca
Fabbrocini, Gabriella
di Vico, Francesca
Costa, Claudia
Scalvenzi, Massimiliano
author_facet Villani, Alessia
Potestio, Luca
Fabbrocini, Gabriella
di Vico, Francesca
Costa, Claudia
Scalvenzi, Massimiliano
author_sort Villani, Alessia
collection PubMed
description
format Online
Article
Text
id pubmed-9787710
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher John Wiley & Sons, Inc.
record_format MEDLINE/PubMed
spelling pubmed-97877102022-12-28 Long‐term efficacy of telemedicine for patients with locally advanced basal cell carcinoma during COVID‐19 pandemic Villani, Alessia Potestio, Luca Fabbrocini, Gabriella di Vico, Francesca Costa, Claudia Scalvenzi, Massimiliano Dermatol Ther Letters John Wiley & Sons, Inc. 2022-09-05 2022-11 /pmc/articles/PMC9787710/ /pubmed/36018282 http://dx.doi.org/10.1111/dth.15786 Text en © 2022 The Authors. Dermatologic Therapy published by Wiley Periodicals LLC. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article under the terms of the http://creativecommons.org/licenses/by-nc-nd/4.0/ (https://creativecommons.org/licenses/by-nc-nd/4.0/) License, which permits use and distribution in any medium, provided the original work is properly cited, the use is non‐commercial and no modifications or adaptations are made.
spellingShingle Letters
Villani, Alessia
Potestio, Luca
Fabbrocini, Gabriella
di Vico, Francesca
Costa, Claudia
Scalvenzi, Massimiliano
Long‐term efficacy of telemedicine for patients with locally advanced basal cell carcinoma during COVID‐19 pandemic
title Long‐term efficacy of telemedicine for patients with locally advanced basal cell carcinoma during COVID‐19 pandemic
title_full Long‐term efficacy of telemedicine for patients with locally advanced basal cell carcinoma during COVID‐19 pandemic
title_fullStr Long‐term efficacy of telemedicine for patients with locally advanced basal cell carcinoma during COVID‐19 pandemic
title_full_unstemmed Long‐term efficacy of telemedicine for patients with locally advanced basal cell carcinoma during COVID‐19 pandemic
title_short Long‐term efficacy of telemedicine for patients with locally advanced basal cell carcinoma during COVID‐19 pandemic
title_sort long‐term efficacy of telemedicine for patients with locally advanced basal cell carcinoma during covid‐19 pandemic
topic Letters
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9787710/
https://www.ncbi.nlm.nih.gov/pubmed/36018282
http://dx.doi.org/10.1111/dth.15786
work_keys_str_mv AT villanialessia longtermefficacyoftelemedicineforpatientswithlocallyadvancedbasalcellcarcinomaduringcovid19pandemic
AT potestioluca longtermefficacyoftelemedicineforpatientswithlocallyadvancedbasalcellcarcinomaduringcovid19pandemic
AT fabbrocinigabriella longtermefficacyoftelemedicineforpatientswithlocallyadvancedbasalcellcarcinomaduringcovid19pandemic
AT divicofrancesca longtermefficacyoftelemedicineforpatientswithlocallyadvancedbasalcellcarcinomaduringcovid19pandemic
AT costaclaudia longtermefficacyoftelemedicineforpatientswithlocallyadvancedbasalcellcarcinomaduringcovid19pandemic
AT scalvenzimassimiliano longtermefficacyoftelemedicineforpatientswithlocallyadvancedbasalcellcarcinomaduringcovid19pandemic

Ejemplares similares